NEW YORK (GenomeWeb) – IntegraGen and GoPath Laboratories said today that they have signed a non-exclusive licensing agreement under which GoPath plans to commercialize a test based on IntegraGen's proprietary miR-31-3p biomarker in the US and Canada.